SEC Form 4 · accession 0001209191-16-132034
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lyle J Arnold
Officer — SR VP of R&D and CSO
Period of report
Jul 6, 2016
Accepted (ET)
Jul 7, 2016 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 6, 2016 | A | 50,000 | $0.00 | A | 60,714 | D |
Table II — derivative securities
No Table II lines on this filing.